114 related articles for article (PubMed ID: 37207916)
1. Final step of B-cell differentiation into plasmablasts; the right time to activate plasma cell PIM2 kinase.
Haas M; Fest T
Immunol Lett; 2023 Jun; 258():45-50. PubMed ID: 37207916
[TBL] [Abstract][Full Text] [Related]
2. PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma.
Haas M; Caron G; Chatonnet F; Manenti S; Alaterre E; Devin J; Delaloy C; Bertolin G; Viel R; Pignarre A; Llamas-Gutierrez F; Marchalot A; Decaux O; Tarte K; Delpy L; Moreaux J; Fest T
Blood; 2022 Apr; 139(15):2316-2337. PubMed ID: 35108359
[TBL] [Abstract][Full Text] [Related]
3. Proviral insertion in murine lymphomas 2 promotes stomach cancer progression by regulating apoptosis via reactive oxygen species-triggered endoplasmic reticulum stress.
Xin H; Deng Y; Cao J
Biochem Biophys Res Commun; 2018 Nov; 506(1):145-152. PubMed ID: 30340823
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression.
Kronschnabl P; Grünweller A; Hartmann RK; Aigner A; Weirauch U
Int J Oncol; 2020 Feb; 56(2):448-459. PubMed ID: 31894300
[TBL] [Abstract][Full Text] [Related]
5. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway.
Liu H; Zhang C; Liang T; Song J; Hao J; Hou G
Cell Mol Immunol; 2012 Nov; 9(6):503-10. PubMed ID: 23085945
[TBL] [Abstract][Full Text] [Related]
7. Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation.
Agrawal S; Koschmieder S; Bäumer N; Reddy NG; Berdel WE; Müller-Tidow C; Serve H
Leukemia; 2008 Jan; 22(1):78-86. PubMed ID: 17943165
[TBL] [Abstract][Full Text] [Related]
8. PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a.
Zajkowicz A; Krześniak M; Gdowicz-Kłosok A; Łasut B; Rusin M
Arch Biochem Biophys; 2018 Oct; 655():26-36. PubMed ID: 30096294
[TBL] [Abstract][Full Text] [Related]
9. Expression of the PIM2 gene is associated with more aggressive clinical course in patients with chronic lymphocytic leukemia.
Kapelko-Słowik K; Dybko J; Grzymajło K; Jaźwiec B; Urbaniak-Kujda D; Słowik M; Potoczek S; Wołowiec D
Adv Clin Exp Med; 2019 Mar; 28(3):385-390. PubMed ID: 30525315
[TBL] [Abstract][Full Text] [Related]
10. RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.
Hospital MA; Jacquel A; Mazed F; Saland E; Larrue C; Mondesir J; Birsen R; Green AS; Lambert M; Sujobert P; Gautier EF; Salnot V; Le Gall M; Decroocq J; Poulain L; Jacque N; Fontenay M; Kosmider O; Récher C; Auberger P; Mayeux P; Bouscary D; Sarry JE; Tamburini J
Leukemia; 2018 Mar; 32(3):597-605. PubMed ID: 28914261
[TBL] [Abstract][Full Text] [Related]
11. Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Kapelko-Slowik K; Owczarek TB; Grzymajlo K; Urbaniak-Kujda D; Jazwiec B; Slowik M; Kuliczkowski K; Ugorski M
Leuk Lymphoma; 2016 Sep; 57(9):2140-9. PubMed ID: 26764044
[TBL] [Abstract][Full Text] [Related]
12. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.
Gómez-Abad C; Pisonero H; Blanco-Aparicio C; Roncador G; González-Menchén A; Martinez-Climent JA; Mata E; Rodríguez ME; Muñoz-González G; Sánchez-Beato M; Leal JF; Bischoff JR; Piris MA
Blood; 2011 Nov; 118(20):5517-27. PubMed ID: 21937691
[TBL] [Abstract][Full Text] [Related]
13. RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation.
Bednarski JJ; Nickless A; Bhattacharya D; Amin RH; Schlissel MS; Sleckman BP
J Exp Med; 2012 Jan; 209(1):11-7. PubMed ID: 22201128
[TBL] [Abstract][Full Text] [Related]
14. TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.
Whillock AL; Mambetsariev N; Lin WW; Stunz LL; Bishop GA
Sci Rep; 2019 Sep; 9(1):12884. PubMed ID: 31501481
[TBL] [Abstract][Full Text] [Related]
15. A regulatory feedback loop between HIF-1α and PIM2 in HepG2 cells.
Yu Z; Zhao X; Ge Y; Zhang T; Huang L; Zhou X; Xie L; Liu J; Huang G
PLoS One; 2014; 9(2):e88301. PubMed ID: 24505470
[TBL] [Abstract][Full Text] [Related]
16. Proviral integration site 2 is required for interleukin-6 expression induced by interleukin-1, tumour necrosis factor-α and lipopolysaccharide.
Yang J; Li X; Hanidu A; Htut TM; Sellati R; Wang L; Jiang H; Li J
Immunology; 2010 Oct; 131(2):174-82. PubMed ID: 20465571
[TBL] [Abstract][Full Text] [Related]
17. PIM2 deletion alleviates lipopolysaccharide (LPS)-induced respiratory distress syndrome (ARDS) by suppressing NLRP3 inflammasome.
Wang F; Xu L; Dong G; Zhu M; Liu L; Wang B
Biochem Biophys Res Commun; 2020 Dec; 533(4):1419-1426. PubMed ID: 33333710
[TBL] [Abstract][Full Text] [Related]
18. PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
[TBL] [Abstract][Full Text] [Related]
19. Pim2 is important for regulating DNA damage response in multiple myeloma cells.
Ramachandran J; Santo L; Siu KT; Panaroni C; Raje N
Blood Cancer J; 2016 Aug; 6(8):e462. PubMed ID: 27564460
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of PIM2 by Underexpression of MicroRNA-135-5p Improves Survival Rates of Skin Allografts by Suppressing Apoptosis of Fibroblast Cells.
Zhang H
Med Sci Monit; 2017 Jan; 23():107-113. PubMed ID: 28064305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
